Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation

By Hong Bo  

Investigational New Drugs, Vol. 29, Iss. 3, 2011-06 ,pp. : 401-410

Springer Publishing Company

Access to resources Recommend Favorite

Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells

By Terada Takeshi   Mizobata Miki   Kawakami Shigeru   Yabe Yoshiyuki   Yamashita Fumiyoshi   Hashida Mitsuru  

Journal of Drug Targeting, Vol. 14, Iss. 8, 2006-09 ,pp. : 536-545

Informa Healthcare

Access to resources Recommend Favorite

Neuroprotection in Hypoxic-Ischemic Brain Injury Targeting Glial Cells

By  

Current Pharmaceutical Design, Vol. 23, Iss. 26, 2017-10 ,pp. : 3899-3906

Bentham Science Publishers

Access to resources Recommend Favorite

Phospholipid Microspheres: A Novel Delivery Mode for Targeting Antileishmanial Agent in Experimental Leishmaniasis

By Medda S.   Jaisankar P.   Manna R.K.   Pal B.   Giri V.S.   Basu M.K.  

Journal of Drug Targeting, Vol. 11, Iss. 2, 2003-01 ,pp. : 123-128

Informa Healthcare

Access to resources Recommend Favorite

Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas

By Laarhoven H.   Gambarota G.   Heerschap A.   Lok J.   Verhagen I.   Corti A.   Toma S.   Stampino C.   Kogel A.   Punt C.  

Investigational New Drugs, Vol. 24, Iss. 1, 2006-01 ,pp. : 27-36

Springer Publishing Company

Access to resources Recommend Favorite